L-(-)-α-Methyldopa hydrate

• CAT Number: I003502
• CAS Number: 41372-08-1
• Molecular Formula: C10H13NO4 . 3/2 H2O
• Molecular Weight: 238.24
• Purity: ≥95%
• Target: Neuronal Signaling
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• IUPAC Name: (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;hydrate
• InChI: InChI=1S/C10H13NO4.H2O/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6;/h2-4,12-13H,5,11H2,1H3,(H,14,15);1H2/t10-;/m0./s1
• InChIKey: XDJUBZFLFDODNF-PPHPATTJSA-N
• SMILES: C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.O

L-(-)-α-Methyldopa hydrate（Cat No.:I003502）is a medication primarily used in the treatment of hypertension (high blood pressure). It is a central alpha-2 adrenergic agonist, which works by stimulating receptors in the brain that reduce sympathetic nervous system activity, leading to a decrease in blood pressure. L-(-)-α-Methyldopa hydrate is often used during pregnancy for treating gestational hypertension or preeclampsia due to its relatively safer profile compared to other antihypertensives. Common side effects include drowsiness, dry mouth, and dizziness. It is typically prescribed when other blood pressure-lowering medications are unsuitable or ineffective.